KK
KLP Kapitalforvaltning Portfolio holdings
AUM
$23.2B
This Quarter Return
+4.67%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$21.1B
AUM Growth
–
Cap. Flow
+$21.1B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
31.62%
Holding
2,288
New
2,288
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Apple
AAPL
|
$1.45B |
| 2 |
NVIDIA
NVDA
|
$1.23B |
| 3 |
Microsoft
MSFT
|
$1.12B |
| 4 |
Amazon
AMZN
|
$698M |
| 5 |
Meta Platforms (Facebook)
META
|
$447M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 32.86% |
| 2 | Financials | 13.45% |
| 3 | Consumer Discretionary | 11.11% |
| 4 | Healthcare | 10.73% |
| 5 | Communication Services | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Clearfield
CLFD
$450M
| $74.4K | ﹤0.01% | +2,400 | New | +$74.4K |
|
|
RVNC
2177
DELISTED
Revance Therapeutics, Inc.
RVNC
| $74.2K | ﹤0.01% | +24,400 | New | +$74.2K |
|
2178
Phathom Pharmaceuticals
PHAT
$864M
| $73.9K | ﹤0.01% | +9,100 | New | +$73.9K |
|
|
LGF.A
2179
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $73.4K | ﹤0.01% | +8,600 | New | +$73.4K |
|
2180
Astronics
ATRO
$1.29B
| $73.4K | ﹤0.01% | +4,600 | New | +$73.4K |
|
2181
Evolv Technologies
EVLV
$1.42B
| $73.1K | ﹤0.01% | +18,500 | New | +$73.1K |
|
2182
ARS Pharmaceuticals
SPRY
$1.15B
| $72.8K | ﹤0.01% | +6,900 | New | +$72.8K |
|
2183
Anywhere Real Estate
HOUS
$684M
| $72.6K | ﹤0.01% | +22,000 | New | +$72.6K |
|
2184
MindMed
MNMD
$676M
| $72.4K | ﹤0.01% | +10,400 | New | +$72.4K |
|
|
PKST
2185
Peakstone Realty Trust
PKST
$468M
| $72.1K | ﹤0.01% | +6,400 | New | +$72.1K |
|
2186
LSB Industries
LXU
$599M
| $71.3K | ﹤0.01% | +9,400 | New | +$71.3K |
|
2187
Semrush
SEMR
$1.17B
| $71.3K | ﹤0.01% | +6,000 | New | +$71.3K |
|
2188
Arcturus Therapeutics
ARCT
$462M
| $71.3K | ﹤0.01% | +4,200 | New | +$71.3K |
|
2189
Covenant Logistics
CVLG
$604M
| $70.9K | ﹤0.01% | +1,300 | New | +$70.9K |
|
|
CMRC
2190
Commerce.com, Inc. Series 1 Common Stock
CMRC
$375M
| $70.4K | ﹤0.01% | +11,500 | New | +$70.4K |
|
2191
Standard BioTools
LAB
$481M
| $70.3K | ﹤0.01% | +40,166 | New | +$70.3K |
|
|
NXDR
2192
Nextdoor Holdings
NXDR
$794M
| $69.9K | ﹤0.01% | +29,500 | New | +$69.9K |
|
2193
LendingTree
TREE
$925M
| $69.8K | ﹤0.01% | +1,800 | New | +$69.8K |
|
2194
Erasca
ERAS
$445M
| $68.8K | ﹤0.01% | +27,400 | New | +$68.8K |
|
2195
Theravance Biopharma
TBPH
$699M
| $68.7K | ﹤0.01% | +7,300 | New | +$68.7K |
|
2196
Arhaus
ARHS
$1.65B
| $68.6K | ﹤0.01% | +7,300 | New | +$68.6K |
|
2197
Greif Class B
GEF.B
$2.65B
| $68.5K | ﹤0.01% | +1,000 | New | +$68.5K |
|
2198
Granite Ridge Resources
GRNT
$730M
| $68.5K | ﹤0.01% | +10,600 | New | +$68.5K |
|
2199
Distribution Solutions Group
DSGR
$1.49B
| $68.4K | ﹤0.01% | +1,988 | New | +$68.4K |
|
2200
Donegal Group Class A
DGICA
$653M
| $68.1K | ﹤0.01% | +4,400 | New | +$68.1K |
|